Canada Life’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Buy
113,625
+3,277
+3% +$301K 0.02% 515
2025
Q4
$9.93M Sell
110,348
-129,991
-54% -$12.3M 0.02% 520
2025
Q3
$23.6M Sell
240,339
-15,471
-6% -$1.53M 0.03% 396
2025
Q2
$23.4M Sell
255,810
-3,246
-1% -$314K 0.04% 377
2025
Q1
$29.4M Sell
259,056
-775
-0.3% -$82.9K 0.05% 318
2024
Q4
$27.4M Buy
259,831
+33,137
+15% +$3.56M 0.05% 329
2024
Q3
$24.5M Sell
226,694
-3,647
-2% -$398K 0.04% 368
2024
Q2
$25M Buy
230,341
+1,108
+0.5% +$131K 0.05% 341
2024
Q1
$30.3M Buy
229,233
+15,548
+7% +$1.94M 0.06% 297
2023
Q4
$25.9M Sell
213,685
-2,878
-1% -$321K 0.06% 318
2023
Q3
$24.3M Sell
216,563
-478
-0.2% -$60.7K 0.06% 313
2023
Q2
$31.8M Buy
217,041
+40,529
+23% +$5.51M 0.08% 263
2023
Q1
$22.8M Buy
176,512
+2,798
+2% +$351K 0.06% 325
2022
Q4
$22.3M Buy
173,714
+6,807
+4% +$790K 0.06% 324
2022
Q3
$17.5M Sell
166,907
-1,648
-1% -$181K 0.05% 371
2022
Q2
$17.7M Buy
168,555
+6,557
+4% +$778K 0.05% 384
2022
Q1
$21.8M Sell
161,998
-6,589
-4% -$794K 0.05% 378
2021
Q4
$20.7M Sell
168,587
-1,303
-0.8% -$171K 0.04% 407
2021
Q3
$24.3M Sell
169,890
-2,702
-2% -$397K 0.06% 351
2021
Q2
$26.9M Sell
172,592
-10,812
-6% -$1.75M 0.06% 330
2021
Q1
$28.3M Buy
183,404
+7,093
+4% +$1.1M 0.07% 304
2020
Q4
$26.3M Buy
176,311
+5,899
+3% +$833K 0.05% 363
2020
Q3
$22.5M Buy
170,412
+8,623
+5% +$1.13M 0.05% 359
2020
Q2
$18.7M Sell
161,789
-5,347
-3% -$616K 0.04% 377
2020
Q1
$16.5M Buy
167,136
+3,719
+2% +$488K 0.04% 344
2019
Q4
$23.6M Buy
163,417
+3,947
+2% +$545K 0.05% 352
2019
Q3
$21.3M Sell
159,470
-3,502
-2% -$452K 0.05% 368
2019
Q2
$18.6M Buy
162,972
+1,404
+0.9% +$164K 0.04% 395
2019
Q1
$20M Buy
161,568
+29,107
+22% +$3.31M 0.05% 328
2018
Q4
$12.7M Buy
132,461
+637
+0.5% +$71.6K 0.04% 402
2018
Q3
$16.8M Sell
131,824
-20,347
-13% -$2.42M 0.04% 379
2018
Q2
$16.5M Buy
152,171
+613
+0.4% +$66.7K 0.04% 386
2018
Q1
$16.1M Sell
151,558
-3,599
-2% -$418K 0.04% 398
2017
Q4
$18.2M Buy
155,157
+2,510
+2% +$284K 0.04% 378
2017
Q3
$17.1M Buy
152,647
+5,055
+3% +$584K 0.04% 377
2017
Q2
$18.4M Sell
147,592
-42,540
-22% -$5.04M 0.05% 352
2017
Q1
$22.5M Sell
190,132
-135,106
-42% -$15.3M 0.06% 306
2016
Q4
$32.7M Sell
325,238
-7,281
-2% -$780K 0.09% 225
2016
Q3
$42M Buy
332,519
+115,562
+53% +$14.3M 0.12% 178
2016
Q2
$25.3M Buy
216,957
+61,485
+40% +$6.96M 0.08% 263
2016
Q1
$16.1M Buy
155,472
+12,840
+9% +$1.24M 0.06% 305
2015
Q4
$14.2M Sell
142,632
-47,012
-25% -$4.6M 0.05% 321
2015
Q3
$17.3M Buy
189,644
+9,287
+5% +$931K 0.07% 283
2015
Q2
$19.1M Sell
180,357
-13,760
-7% -$1.52M 0.07% 298
2015
Q1
$22.1M Sell
194,117
-2,437
-1% -$278K 0.08% 283
2014
Q4
$21.6M Sell
196,554
-62,216
-24% -$6.56M 0.07% 287
2014
Q3
$25.3M Buy
258,770
+39,932
+18% +$3.93M 0.08% 249
2014
Q2
$22M Buy
218,838
+6,495
+3% +$634K 0.07% 281
2014
Q1
$19.4M Buy
212,343
+24,680
+13% +$2.27M 0.07% 296
2013
Q4
$17M Buy
187,663
+14,740
+9% +$1.28M 0.06% 317
2013
Q3
$13.8M Buy
172,923
+68,394
+65% +$5.38M 0.05% 319
2013
Q2
$7.61M Buy
+104,529
New +$7.82M 0.05% 287

Other funds holding ZBH

Canada Life's ZBH Position: Q1 2026 in Review

Canada Life increased its Zimmer Biomet (ZBH) stake by 3% in Q1 2026, buying an estimated $301K and bringing the position to 113,625 shares worth $10.3M. The position accounts for 0.02% of the portfolio, ranked #515.

Canada Life first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $42M in Q3 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Canada Life held 113,625 shares of Zimmer Biomet worth $10.3M as of Q1 2026.
  • Canada Life bought 3,277 Zimmer Biomet shares in Q1 2026, an estimated $301K.
  • Zimmer Biomet made up 0.02% of Canada Life's portfolio in Q1 2026, its #515 holding.
  • Canada Life first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Zimmer Biomet position peaked at $42M in Q3 2016.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.